These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1524946)

  • 1. [Evaluation of antibody specificity of the monoclonal component in a case of Waldenström's macroglobulinemia].
    Giovanna Zaninetta M; Moccia F; Paolo Mazzarello G; Mansuino P; Morra L
    Ann Ital Med Int; 1992; 7(1):42-5. PubMed ID: 1524946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Waldenström's macroglobulinemia with preserved antierythrocyte and antilipoprotein antibody activity].
    Zittoun R; Beaumont JL; Homberg JC; Carbonniere C; Debre P; Bousser J
    Sem Hop; 1975 Dec; 51(48):2943-8. PubMed ID: 175506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anti-smooth-muscle antibody activity of monoclonal IgM in Waldenström's disease].
    Krulik M; Vittecoq D; Abuaf N; Genot JY; Homberg JC; Debray J
    Sem Hop; 1983 Jun; 59(23):1737-41. PubMed ID: 6308799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphoplasmacytic lymphoma with IgA paraproteinemia mimicking Waldenstrom's Macroglobulinemia.
    Basu D; Pathak D; Shyambabu C; Koner BC; Swaminathan RP
    Indian J Pathol Microbiol; 2004 Oct; 47(4):515-7. PubMed ID: 16295380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Waldenström's macroglobulinemia].
    Arderiu Freixa A; Ordi Ros J; Mirada Canals A
    Rev Clin Esp; 1981 Nov; 163(3):151-6. PubMed ID: 6799992
    [No Abstract]   [Full Text] [Related]  

  • 6. Cross-idiotypic antigens among monoclonal immunoglobulin M from patients with Waldenström's macroglobulinemia and polyneuropathy.
    Dellagi K; Brouet JC; Danon F
    J Clin Invest; 1979 Nov; 64(5):1530-4. PubMed ID: 91626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Waldenström's macroglobulinemia with IgG monoclonal component].
    Morey M; Bargay J; Durán MA; Matamoros N
    Med Clin (Barc); 1992 Mar; 98(11):436-7. PubMed ID: 1569796
    [No Abstract]   [Full Text] [Related]  

  • 8. Utility of monoclonal antibodies to define different stages of maturation of B cells in Waldenström's macroglobulinemia.
    Volpe S; Cantore N; Fotino A; Pagnini D; Volpe E
    Haematologica; 1985; 70(3):274. PubMed ID: 3932166
    [No Abstract]   [Full Text] [Related]  

  • 9. [Waldenström's macroglobulinemia with an uncommon presentation].
    Trueba F; Maslin J; Coutant G; Guymar S; Vigezzi JF; Desangles F; Nizou JY; Nicand E
    Ann Biol Clin (Paris); 2006; 64(1):73-5. PubMed ID: 16420993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Waldenström's macroglobulin with anti-G3m(b1) antibody activity.
    Ota T; Oda S; Chiba S; Suzuki H; Eto S
    J Immunol; 1991 Mar; 146(6):1880-4. PubMed ID: 1706383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular carcinoma followed by Waldenström's macroglobulinemia: a case report.
    Hasegawa K; Kubota K; Hirai H; Imai Y; Midorikawa Y; Makuuchi M
    Hepatogastroenterology; 2000; 47(33):842-5. PubMed ID: 10919044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Waldenstrom's macroglobulinemia].
    Geller LI
    Probl Gematol Pereliv Krovi; 1969 Feb; 14(2):40-9. PubMed ID: 4981803
    [No Abstract]   [Full Text] [Related]  

  • 13. Severe immune thrombocytopenia secondary to Waldenström's macroglobulinemia with anti-GPIb/IX monoclonal IgM antibody.
    Yamanouchi J; Hato T; Niiya T; Azuma T; Yasukawa M
    Ann Hematol; 2014 Apr; 93(4):711-2. PubMed ID: 23892928
    [No Abstract]   [Full Text] [Related]  

  • 14. [Biochemical, physico-chemical and immunochemical aspects of Waldenström's macroglobulinemia].
    Mesnier F
    J Med Bord; 1967 Sep; 144(9):1249-66. PubMed ID: 4194653
    [No Abstract]   [Full Text] [Related]  

  • 15. Secretory piece and IgA deficiency in a patient with Waldenstrom's macroglobulinemia.
    Nussinson E; Lahav M; Berebi A; Estrov Z; Zur S; Resnitzky P
    Am J Gastroenterol; 1986 Oct; 81(10):995-8. PubMed ID: 3094364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD20-directed antibody-mediated immunotherapy induces responses and facilitates hematologic recovery in patients with Waldenstrom's macroglobulinemia.
    Treon SP; Agus TB; Link B; Rodrigues G; Molina A; Lacy MQ; Fisher DC; Emmanouilides C; Richards AI; Clark B; Lucas MS; Schlossman R; Schenkein D; Lin B; Kimby E; Anderson KC; Byrd JC
    J Immunother; 2001; 24(3):272-9. PubMed ID: 11394506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Waldenström's macroglobulinemia and myasthenia gravis.
    Bartoloni C; Scoppetta C; Flamini G; Guidi L; Bartoccioni E; Lambiase M; Gambassi G; Terranova T
    J Clin Lab Immunol; 1981 Nov; 6(3):275-8. PubMed ID: 6802976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal cryoglobulins and pyroglobulins.
    Tichý M; Hrncír Z; Malý J; Sakalová A; Matĕja F; Mracek J
    Neoplasma; 1984; 31(4):381-4. PubMed ID: 6433211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired von Willebrand's syndrome in the course of Waldenström's disease.
    Mazurier C; Parquet-Gernez A; Descamps J; Bauters F; Goudemand M
    Thromb Haemost; 1980 Dec; 44(3):115-8. PubMed ID: 6781094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serum protein immunofixation in malignant hemopathies other than multiple myeloma and Waldenstrom's macroglobulinemia].
    Ramont L; Ngoc PT; Pignon B; Maquart FX
    Ann Biol Clin (Paris); 2002; 60(5):565-70. PubMed ID: 12368142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.